Published in Biol Pharm Bull on January 01, 2004
Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use. J Gen Intern Med (2008) 1.06
Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits. J Vet Sci (2006) 0.75
Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull (2005) 1.42
Tissue distribution after intravenous dosing of micafungin, an antifungal drug, to rats. Biol Pharm Bull (2004) 1.30
Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev (2009) 1.05
Identification of cytochrome P450 enzymes involved in the metabolism of FK228, a potent histone deacetylase inhibitor, in human liver microsomes. Biol Pharm Bull (2005) 1.04
Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. Drug Metab Dispos (2003) 1.03
Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. Br J Pharmacol (2005) 0.95
Second morning urine method is superior to the casual urine method for estimating daily salt intake in patients with hypertension. Hypertens Res (2012) 0.91
Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes. Biol Pharm Bull (2005) 0.87
Geranylgeranylacetone suppresses noise-induced expression of proinflammatory cytokines in the cochlea. Auris Nasus Larynx (2011) 0.86
Investigation of the electrochemical oxidation products of zotepine and their fragmentation using on-line electrochemistry/electrospray ionization mass spectrometry. J Mass Spectrom (2006) 0.83
The influence of posture on the estimation of daily salt intake by the second morning urine method. Hypertens Res (2010) 0.83
Pharmacokinetics and tissue distribution of tacrolimus (FK506) after a single or repeated ocular instillation in rabbits. J Ocul Pharmacol Ther (2008) 0.82
Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. Yakugaku Zasshi (2007) 0.81
Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population. Drug Metab Pharmacokinet (2004) 0.80
Utility of microtiter plate assays for human cytochrome P450 inhibition studies in drug discovery: application of simple method for detecting quasi-irreversible and irreversible inhibitors. Drug Metab Pharmacokinet (2004) 0.80
Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes. Biol Pharm Bull (2004) 0.79
Strategy for structural elucidation of drugs and drug metabolites using (MS)n fragmentation in an electrospray ion trap. J Mass Spectrom (2003) 0.78
[Drug-drug interaction of antifungal drugs]. Yakugaku Zasshi (2005) 0.78
Pharmacokinetics-pharmacodynamics of micafungin in Japanese patients with deep-seated mycosis. Eur J Drug Metab Pharmacokinet (2006) 0.78
[A case of right mesial temporal lobe epilepsy accompanied with ictal polyopsia]. Rinsho Shinkeigaku (2004) 0.77
Evidence for singlet oxygen involvement in rat and human cytochrome P450-dependent substrate oxidations. Drug Metab Pharmacokinet (2002) 0.77
Contribution of human hepatic cytochrome p450 isoforms to the metabolism of psychotropic drugs. Biol Pharm Bull (2005) 0.76
[Effect of genetic polymorphism of cytochrome P450 3A and transporter gene on pharmacokinetics of tacrolimus, a calcineurin inhibitor]. Nihon Yakurigaku Zasshi (2006) 0.75
Strategy for structure elucidation of drug metabolites derived from protonated molecules and (MS)n fragmentation of zotepine, tiaramide and their metabolites. Drug Metab Pharmacokinet (2002) 0.75
Interindividual variability in 2-hydroxylation, 3-sulfation, and 3-glucuronidation of ethynylestradiol in human liver. Biol Pharm Bull (2004) 0.75
Mechanism of voluntary and involuntary movements in humans. Suppl Clin Neurophysiol (2006) 0.75
New SRM data dependent exclusion (MS)n measurement for structural determination of drug metabolites using LC/ESI/Ion trap MS. Drug Metab Pharmacokinet (2003) 0.75
Rhythmic EMG and EEG activity during voluntary movement in posthypoxic cortical action myoclonus. J UOEH (2005) 0.75
High-frequency oscillations in the human motor system. Suppl Clin Neurophysiol (2006) 0.75
Dissociation constants of phenothiazine drugs incorporated in phosphatidylcholine bilayer of small unilamellar vesicles as determined by carbon-13 nuclear magnetic resonance spectrometric titration. Biochim Biophys Acta (2004) 0.75
Interindividual variability in 5-Fluorouracil metabolism and procainamide N-acetylation in human liver cytosol. Biol Pharm Bull (2005) 0.75
CT features of early pheochromocytoma. Intern Med (2011) 0.75
[Case report; thyroid hormone resistance found in a patient with neuroendocrine tumor]. Nihon Naika Gakkai Zasshi (2011) 0.75
No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug. Biol Pharm Bull (2005) 0.75
Recurrent herpes simplex virus type 2 meningitis: a case report of Mollaret's meningitis. Jpn J Infect Dis (2002) 0.75
Unilateral positive-negative myoclonus in Creutzfeldt-Jakob disease. Mov Disord (2006) 0.75